implications of this is that logical replacement therapy should probably be based on the production rate; this amounts to approximately 15 ,ug/kg/day.
(2) Although it is obvious that clinicians should want to reduce the number of injections given to children to the minimum, this should not be allowed to compromise the efficacy of treatment. The situation is similar to that with insulin in diabetic children, and it is never advised that this be given only twice weekly. Since growth hormone can be given subcutaneously it is logical that children with growth hormone deficiency should be taught to give their own injections of growth hormone in the same way as diabetic children. By the very nature of their problem it will be necessary to continue only until epiphysial fusion occurs and not for life. This treatment schedule, if it were shown to be effective, would mean a considerable saving in growth hormone and could make it more widely available for countries not quite so fortunate as our own.
(3) All new therapeutic substances go through a stage of assessment of efficacy and safety before being made generally available. With growth hormone we feel that this stage was passed several years ago and that treatment and assessment of response to the hormone can now be carried out by a much larger group of hospitals, especially those with recognised paediatric and endocrine units with facilities for diagnosing growth hormone deficiency. This would involve making supplies of the growth hormone available to these units (perhaps the participation of the DHSS in growth hormone production is a signal that is about to happen) and would improve the convenience of follow-up and ensure continuity of care for the patients.
This does not mean that the growth assessment centres are no longer necessary; there remains much to learn about the best ways of treating these patients. We would like to see a trial of growth hormone treatment given by frequent and smaller dosage regimens assessed both by development and measurement of somatomedins. This is a trial that could conveniently be arranged through the existing 
